NanoViricides, Inc. (NNVC) analyst actions
Rating and price-target actions on NNVC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NNVC overview →
1 measured NNVC analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily | Press release | +2.76% | +6.90% |
Keep exploring
More NNVC: earnings → · SEC filings → · NNVC overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Minerva Neurosciences, Inc (NERV) | 164 | 0.00% | 48% |
| NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA (NITE) | 164 | -0.04% | 28% |
| Matinas Biopharma Holdings, Inc. (MTNB) | 161 | -0.53% | 39% |
| NanoVibronix, Inc. (NAOV) | 161 | -0.40% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.